Moderna, Inc.

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 60770K107 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Capital World Investors 13G	5.6%	22,276,996	13G	8/12/2026 Event 6/30/2026
FMR LLC 13G/A Amendment 2	13.1%	51,803,891.34	13G/A Amendment 2	8/6/2026 Event 6/30/2026
FMR LLC	13.1%	51,803,891.34
Abigail P. Johnson	13.1%	51,803,891.34
Baillie Gifford & Co 13G/A Amendment 7	4.6%	18,206,778	13G/A Amendment 7	7/24/2026 Event 6/30/2026
Vanguard Capital Management LLC 13G	6.5%	25,933,824	13G	4/30/2026 Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 6	0%	0	13G/A Amendment 6	3/27/2026 Event 3/13/2026
Baillie Gifford & Co 13G/A Amendment 6	5.3%	20,580,514	13G/A Amendment 6	2/9/2026 Event 12/31/2025
FMR LLC 13G/A Amendment 1	10.6%	41,301,468.88	13G/A Amendment 1	2/6/2026 Event 1/30/2026
FMR LLC	10.6%	41,301,468.88
Abigail P. Johnson	10.6%	41,301,468.88
FMR LLC 13G	7.2%	27,961,310.82	13G	2/5/2026 Event 12/31/2025
FMR LLC	7.2%	27,961,310.82
Abigail P. Johnson	7.2%	27,961,310.82
FMR LLC 13G/A Amendment 1	3.2%	12,304,297.37	13G/A Amendment 1	11/5/2025 Event 9/30/2025
FMR LLC	3.2%	12,304,297.37
Abigail P. Johnson	3.2%	12,304,297.37
FMR LLC 13G	5.5%	21,130,029.21	13G	5/12/2025 Event 3/31/2025
FMR LLC	5.5%	21,130,029.21
Abigail P. Johnson	5.5%	21,130,029.21
Baillie Gifford & Co 13G/A Amendment 5	6.5%	24,948,558	13G/A Amendment 5	4/30/2025 Event 3/31/2025
Baillie Gifford & Co 13G/A Amendment 4	10.1%	38,889,571	13G/A Amendment 4	2/12/2025 Event 12/31/2024

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	33	1.31 M	$254 M	$1.62 M
2026 Q2	874	346 M	$22.7 B	$2.97 B
2026 Q1	808	308 M	$15.6 B	$3.11 B
2025 Q4	764	305 M	$9.02 B	$2.54 B
2025 Q3	737	277 M	$7.17 B	$2.19 B
2025 Q2	761	303 M	$8.35 B	$1.91 B
2025 Q1	779	282 M	$8.00 B	$1.57 B
2024 Q4	849	277 M	$11.5 B	$1.82 B
2024 Q3	894	265 M	$17.7 B	$2.05 B
2024 Q2	1,069	269 M	$32.0 B	$2.69 B
2024 Q1	1,010	276 M	$29.4 B	$2.38 B
2023 Q4	991	269 M	$26.8 B	$2.67 B
2023 Q3	990	247 M	$25.9 B	$2.43 B
2023 Q2	1,057	249 M	$30.3 B	$1.90 B
2023 Q1	1,115	273 M	$38.6 B	$2.98 B
2022 Q4	1,178	263 M	$47.6 B	$4.87 B
2022 Q3	1,011	248 M	$29.4 B	$2.34 B
2022 Q2	1,133	245 M	$35.0 B	$2.92 B
2022 Q1	1,122	251 M	$43.3 B	$5.50 B
2021 Q4	1,213	250 M	$63.5 B	$14.1 B
2021 Q3	1,247	243 M	$93.6 B	$16.3 B
2021 Q2	999	229 M	$53.9 B	$7.65 B
2021 Q1	860	210 M	$27.5 B	$3.92 B
2020 Q4	808	201 M	$21.1 B	$4.20 B
2020 Q3	628	206 M	$14.5 B	$1.28 B
2020 Q2	544	220 M	$14.1 B	$770 M
2020 Q1	336	196 M	$5.88 B	$150 M
2019 Q4	177	177 M	$3.45 B	$22.7 M
2019 Q3	151	169 M	$2.69 B	$20.9 M
2019 Q2	161	144 M	$2.10 B	$33.8 M
2019 Q1	115	138 M	$2.80 B	$11.7 M
2018 Q4	83	134 M	$2.02 B	$0